Please assess the completion status of the following clinical trial:

Trial Title: Endovenous Corticosteroid Pulses in Moderate Ulcerative Colitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Ulcerative colitis diagnosis by Lennard-Jones criteria~* ≥18 years~* Left or extended extent of disease~* Moderate flares of ulcerative colitis according to disease activity index (DAI)~* No maintenance therapy or 5ASA treatment~* The patient is available to understand study procedures and to sign the inform consent form~* Inform Consent Form~Exclusion Criteria:~* Previous or current thiopurines, methotrexate or biological treatment~* Administration of systemic corticoids the last 6 months~* Acute or moderate systemic infection~* Diabetes mellitus or arterial hypertension~* Pregnancy or breastfeeding~* Allergic reactions associated to corticosteroids therapy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- methylprednisolone & prednisone (Type: EXPERIMENTAL): Intravenous bolus of methylprednisolone followed by a decreasing conventional course of oral prednisone
- prednisone (Type: ACTIVE_COMPARATOR): A decreasing conventional course of oral prednisone

Based on this trial design, predict the completion outcome and termination type (if applicable).